Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

Source:http://linkedlifedata.com/resource/pubmed/id/21030498

Clin. Cancer Res. 2010 Dec 1 16 23 5873-82

Download in:

View as

General Info

PMID
21030498